Part D Prescription plan changes
- Tuesday, 04 September 2018 13:14
On Thursday, August 30, the Centers for Medicare & Medicaid Services (CMS) issued two guidance documents to provide clarification to plans participating in the Medicare Part D prescription drug program.
- Step therapy and Part B drugs: CMS recently announced Part D plans would be permitted to establish “step therapy” programs for Part B drugs starting in 2019. However, CMS’s announcement raised many questions for Part D plans considering participation in this program in 2019. A new Q&A attempts to answer those questions.
- Indication-based formularies: CMS also released separate guidance that permits Part D plans to develop “indication-based” formularies starting in 2020. Many medications have multiple uses. However, Medicare rules currently require Part D plans to cover a prescription drug without differentiating the conditions for which it is most appropriate. The new rules would change that starting in 2020.
These guidance documents reflect the Trump Administration’s continued interest in reducing prescription drug costs. We expect CMS to announce additional actions in the next several weeks.
Are you getting money back from your Medical Carrier?
- Tuesday, 04 September 2018 13:10
Its rebate time in New York. Under the MLR Rules of the Affordable Care act, Carriers have to return “excess” premiums received.
Oxford- Large Group Rebate only
United Healthcare- Large Group Rebate only
Horizon- no rebate for large groups
Aetna-right now the word is no rebate in NY and NJ large, although they said most likely there will be rebates in small group NY and NJ
Cigna- no rebates
Emblem- no rebates
Empire- no rebates
Blue Cross South Carolina Formulary Changes
- Saturday, 25 August 2018 07:26
BlueCross BlueShield of South Carolina is announcing some minor updates in its pharmacy policies, including approval of a new glucose monitoring device and additions to some of its drug lists. Most of the changes take effect on Oct. 1, 2018.
We work with an independent panel of BlueCross network physicians and pharmacists, the Pharmacy and Therapeutics Committee, to develop and maintain our drug lists and policies. Clinical decisions are based on drugs’ efficacy, safety and value, with the goal of providing the greatest clinical effectiveness for the lowest cost.
In some cases, member notifications are planned. Please see the Pharmacy department’s bulletin for details.
For more information, please contact your BlueCross Major Group representative.
Texas recoups $839 MM from illegal Obamacare tax
- Saturday, 25 August 2018 07:24
AG Paxton Wins Multistate Obamacare Tax Lawsuit, Recoups Over $839 Million, Including Nearly $305 Million For Texas Taxpayers
MARTY SMITH / STL News
Texas Attorney General Ken Paxton today commended a U.S. District Court decision ordering the Internal Revenue Service to repay Texas and five other states more than $839 million because of an unlawful Obamacare tax on state Medicaid programs. Of that total amount, Texas stands to be repaid $304,730,608.
“Obamacare is unconstitutional, plain and simple,” Attorney General Paxton said. “We all know that the feds cannot tax the states, and we’re proud to return this illegally collected money to the people of Texas.”
In October 2015, Attorney General Paxton led a multistate lawsuit against the federal government over the Obama-era regulation that threatened to choke off Medicaid funds for the health needs of millions of Texas citizens unless Texas taxpayers paid a portion of the Health Insurance Providers Fee to help fund Obamacare.